These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 1958539)

  • 1. Steroids and hypertension.
    Mantero F; Armanini D; Boscaro M; Carpenè G; Fallo F; Opocher G; Rocco S; Scaroni C; Sonino N
    J Steroid Biochem Mol Biol; 1991; 40(1-3):35-44. PubMed ID: 1958539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New aspects of mineralocorticoid hypertension.
    Mantero F; Armanini D; Biason A; Boscaro M; Carpenè G; Fallo F; Opocher G; Rocco S; Scaroni C; Sonino N
    Horm Res; 1990; 34(3-4):175-80. PubMed ID: 2151775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The mineralocorticoid hormone pathways in hypertension with hyperaldosteronism.
    Biglieri EG; Kater CE; Brust N; Chang B; Hirai J
    Clin Exp Hypertens A; 1982; 4(9-10):1677-83. PubMed ID: 7139973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defective fasciculata zone function as the mechanism of glucocorticoid-remediable aldosteronism.
    Ulick S; Chan CK; Gill JR; Gutkin M; Letcher L; Mantero F; New MI
    J Clin Endocrinol Metab; 1990 Nov; 71(5):1151-7. PubMed ID: 2172271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Steroid characteristics of mineralocorticoid adrenocortical hypertension.
    Biglieri EG; Kater CE
    Clin Chem; 1991 Oct; 37(10 Pt 2):1843-8. PubMed ID: 1914200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mineralocorticoids in congenital adrenal hyperplasia.
    Biglieri EG; Kater CE
    J Steroid Biochem Mol Biol; 1991; 40(4-6):493-9. PubMed ID: 1958551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary aldosteronism.
    Gordon RD
    J Endocrinol Invest; 1995; 18(7):495-511. PubMed ID: 9221268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and implications of new types of mineralocorticoid hypertension.
    Biglieri EG; Irony I; Kater CE
    J Steroid Biochem; 1989 Jan; 32(1B):199-204. PubMed ID: 2913410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of the mineralocorticoid hormones in adrenocortical disorders with adrenocorticotropin excess.
    Kater CE; Biglieri EG; Brust N; Chang B; Hirai J
    Clin Exp Hypertens A; 1982; 4(9-10):1749-58. PubMed ID: 6291814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucocorticoid-suppressible aldosteronism: a disorder of the adrenal transitional zone.
    Gomez-Sanchez CE; Gill JR; Ganguly A; Gordon RD
    J Clin Endocrinol Metab; 1988 Sep; 67(3):444-8. PubMed ID: 2842358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigating mineralocorticoid hypertension.
    Nussberger J
    J Hypertens Suppl; 2003 May; 21(2):S25-30. PubMed ID: 12929904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenesis of the type 2 variant of the syndrome of apparent mineralocorticoid excess.
    Ulick S; Tedde R; Mantero F
    J Clin Endocrinol Metab; 1990 Jan; 70(1):200-6. PubMed ID: 2403571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mineralocorticoid-induced hypertension].
    Hensen J; Oelkers W
    Med Klin (Munich); 1997 May; 92(5):273-8. PubMed ID: 9244833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Congenital adrenal hyperplasia].
    Stanić M; Nesović M
    Med Pregl; 1999; 52(11-12):447-54. PubMed ID: 10748766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [In vivo and in vitro studies on 18-hydroxy-11-deoxycorticosterone and 18-hydroxycorticosterone in normal subjects and in those with various adrenocortical disorders (author's transl)].
    Ojima M; Kambegawa A
    Nihon Naibunpi Gakkai Zasshi; 1979 Aug; 55(8):994-1006. PubMed ID: 226427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucocorticoid remediable aldosteronism: a case report.
    Hsieh CJ; Wang PW; Liu JC; Tung SC; Chien WY; Lu YC; Kuo MC
    Changgeng Yi Xue Za Zhi; 1997 Mar; 20(1):52-7. PubMed ID: 9178594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnosis and treatment outcome in primary aldosteronism based on a retrospective analysis of 187 cases].
    Szücs N; Gláz E; Varga I; Tóth M; Kiss R; Patócs A; Jakab C; Perner F; Járay J; Horányi J; Dabasi G; Molnár F; Major L; Füto L; Rácz K; Tulassay Z
    Orv Hetil; 2006 Jan; 147(2):51-9. PubMed ID: 16509213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary aldosteronism: hypertension with a genetic basis.
    Gordon RD; Klemm SA; Tunny TJ; Stowasser M
    Lancet; 1992 Jul; 340(8812):159-61. PubMed ID: 1352575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concurrent hypercortisolism and hypermineralocorticoidism.
    Hogan MJ; Schambelan M; Biglieri EG
    Am J Med; 1977 May; 62(5):777-82. PubMed ID: 871129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of continued adrenocorticotropin stimulation on the mineralocorticoid hormones in classical and nonclassical simple virilizing types of 21-hydroxylase deficiency.
    Kater CE; Biglieri EG; Wajchenberg B
    J Clin Endocrinol Metab; 1985 Jun; 60(6):1057-62. PubMed ID: 2987285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.